TABLE 1.
Demographic data of the participants
| Characteristic | n | % |
|---|---|---|
| Male | 11 | 57.9 |
| Positive SARS‐CoV‐2 vaccination status | 18 | 94.7 |
| Working place | ||
| University hospital | 16 | 84.2 |
| Urban hospital | 1 | 5.3 |
| Rural hospital | 1 | 5.3 |
| Other | 1 | 5.3 |
| Subspecialization in neurology | ||
| Movement disorders | 6 | 31.6 |
| Stroke | 3 | 15.8 |
| Multiple sclerosis | 2 | 10.5 |
| Dementia | 1 | 5.3 |
| Epilepsy | 1 | 5.3 |
| Motor neuron disease | 1 | 5.3 |
| Neurocritical care | 1 | 5.3 |
| Neuroepidemiology | 1 | 5.3 |
| Neuroimmunology | 1 | 5.3 |
| Neuroinfections | 1 | 5.3 |
| N.A. | 1 | 5.3 |
| Were you able to convince people with chronic neurological disease to get vaccinated? | ||
| Sometimes | 12 | 63.2 |
| Frequently | 5 | 26.3 |
| Always | 2 | 10.5 |
Abbreviation: N.A., nonapplicable.